Xenocor Appoints David McNally as Chief Executive Officer, Antony Watson to Chief Commercial Officer and David Van Ness to Chief Technology Officer
Medical device industry veteran to lead expansion of Saberscope™, the market’s first and only single-use video platform for minimally invasive surgery, laparoscopic procedures, and advanced surgical visualization technologies.
Xenocor announces David McNally as CEO and leadership appointments as the company commences commercialization of its recently FDA 510(k)-cleared Saberscope™ surgical visualization system for minimally invasive and laparoscopic surgery.
SALT LAKE CITY, March 18, 2026 /PRNewswire/ — Xenocor, Inc., a developer of advanced surgical visualization and minimally invasive surgery technologies, today announced the appointment of David McNally as Chief Executive Officer. McNally brings more than 40 years of entrepreneurial and executive experience in the medical device industry, including leadership roles in product development, commercialization, and global expansion of innovative therapies, surgical devices and technologies.
In conjunction with McNally’s appointment, the company also announced two executive leadership appointments. Antony Watson has been appointed Chief Commercial Officer, and David Van Ness has been appointed Chief Technology Officer.
